Board Meeting21 Jul 2026, 11:59 am
GlaxoSmithKline Pharmaceuticals Ltd Board Meeting on Aug 3, 2026
AI Summary
GlaxoSmithKline Pharmaceuticals Ltd has announced that its Board of Directors will convene on Monday, August 3, 2026. The primary agenda item for this meeting is to consider, approve, and take on record the Un-audited financial results for the first quarter ended June 30, 2026. This announcement is made in compliance with the Listing Obligations and Disclosure Requirements Regulations, 2015.
Key Highlights
- Board meeting scheduled for August 3, 2026.
- To consider and approve Q1 FY27 un-audited financial results.
- Announcement made as per LODR Regulations.
- Focus on financial performance for the first quarter.
Price Impact
More from GLAXO